Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$103,772,421
-$20,663,513 QoQ
Shares Held
3,248,980
0.0% QoQ
Ownership
5.44%
of shares outstanding
% of Portfolio
2.49%
of 13F equity value
Holder Rank
#6
of 169 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TCG Crossover Management, LLC holds $3,891,479,135 across 48 Biotechnology names. TYRA ranks #12 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
6,007,834 | $800,603,958 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
9,081,201 | $283,878,343 | |
| 3 | CGON |
CG Oncology, Inc.
|
3,670,206 | $260,768,136 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
4,854,436 | $187,866,673 | |
| 5 | IMVT |
Immunovant, Inc.
|
4,457,988 | $171,766,277 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,900,582 | $168,733,669 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,676,624 | $163,437,307 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,062,049 | $124,334,076 |
All Filings in TYRA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,772,421 | 3,248,980 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $124,435,934 | 3,248,980 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $76,191,127 | 2,898,103 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $40,544,460 | 2,898,103 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $27,734,845 | 2,898,103 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,952,357 | 2,898,103 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $27,648,531 | 1,989,103 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $46,763,811 | 1,989,103 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,805,756 | 1,989,103 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $32,621,289 | 1,989,103 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,549,076 | 1,989,103 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,389,948 | 1,989,103 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $33,874,424 | 1,989,103 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,964,885 | 1,989,103 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,117,182 | 1,989,103 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,312,764 | 945,707 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,409,388 | 896,418 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,591,672 | 896,418 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,965,831 | 850,450 | Shares | Sole | 2022-02-18 | |
| No filing history on record for this holder in this stock. | ||||||